Beam

Beam Benefits Recognized As One of Inc. 5000’s Fastest Growing Companies

Retrieved on: 
Tuesday, August 16, 2022 - 6:23pm
808, Industry, CEO, GLOBE, Armed Forces & Police Mutual Benefit Association, Inc, Knowledge, Life, No, 100 Best Workplaces in Europe, Social media, Development, Insurance, Conference, Beam, Overalls, Renewable energy, Health insurance

COLUMBUS, Ohio, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Beam Benefits , the digitally-native employee benefits company, today announced its ranking (No.

Key Points: 
  • COLUMBUS, Ohio, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Beam Benefits , the digitally-native employee benefits company, today announced its ranking (No.
  • This is the first year that Beam has been recognized on Inc.s most prestigious fastest-growing companies list.
  • Todays employees want benefits that are easy to use and understand, and employers are taking note, said Alex Frommeyer, co-founder and CEO of Beam Benefits.
  • Beam Benefits is a digitally-native employee benefits company that offers dental, vision, life, disability, and supplemental health coverage for employers of all sizes.

Beam Global Reports Fiscal Q2 2022 Financial Results

Retrieved on: 
Friday, August 12, 2022 - 9:10pm
CEO, Forward-looking statement, GLOBE, Phrase, YouTube, Absorption, LLC, History, Environment, Net, Cell, EVS, Twitter, SAN, Acquisition, Aviation, EV, Steel, Record, Nasdaq, LinkedIn, Internet, Efficiency, Beam Suntory, Lithium, Video game, Online shopping, Beam

SAN DIEGO, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Beam Global , (Nasdaq: BEEM , BEEMW), (the Company), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media, today announced the financial results for the second fiscal quarter ended June 30, 2022.

Key Points: 
  • SAN DIEGO, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Beam Global , (Nasdaq: BEEM , BEEMW), (the Company), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media, today announced the financial results for the second fiscal quarter ended June 30, 2022.
  • Beam Global reported record second quarter revenues of $3.7 million in the second fiscal quarter of 2022, compared to $2.1 million in the same period in the prior year, an increase of 75%.
  • Management will host a conference call on Friday August 12, 2022 at 4:30 PM ET to review financial results and provide an update on corporate developments.
  • Except to the extent required by law, Beam Global expressly disclaims any obligation to update any forward-looking statements.

Beam Global Schedules Fiscal Second Quarter 2022 Financial Results Conference Call for August 12, 2022 at 4:30 p.m. ET

Retrieved on: 
Saturday, August 6, 2022 - 2:23am
GLOBE, YouTube, Environment, Review, Fiscal, EVS, Twitter, SAN, Aviation, EV, Nasdaq, LinkedIn, Beam, Beam Suntory, Online shopping, Mobile phone

SAN DIEGO, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Beam Global , (Nasdaq: BEEM , BEEMW), (the Company), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media, announced that it will report its Fiscal Second Quarter 2022 financial results on Friday August 12, 2022.

Key Points: 
  • SAN DIEGO, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Beam Global , (Nasdaq: BEEM , BEEMW), (the Company), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media, announced that it will report its Fiscal Second Quarter 2022 financial results on Friday August 12, 2022.
  • Management will host a conference call on Friday August 12, 2022 at 4:30 p.m.
  • ET to review financial results and provide an update on corporate developments.
  • Please dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Beam Global call.

Mesirow Institutional Real Estate Direct Investments Enhances Acquisition Team

Retrieved on: 
Thursday, August 4, 2022 - 4:00pm
Multimedia, Principal, Risk, Chicago real estate bubble of the 1830s, RIA, Industry, Population, Circularity, SEC, Business development, Barron's, Board, Investment banking, Student Investment Advisory Service, Partner, Knowledge, Unemployment, Zurich University of Applied Sciences in Business Administration, Quality of life, Bachelor, The Last Best Place, Acquisition, Beam Suntory, Heitman, Crain's Chicago Business, Business administration, Culture, University, Capital market, LinkedIn, National, Beam, Commercial property, Property management, Science, Investment, Mesirow Financial

Firm hires Will Beam as Managing Director, Acquisitions in Institutional Real Estate Direct Investments, responsible for overseeing all aspects of the acquisition process

Key Points: 
  • Firm hires Will Beam as Managing Director, Acquisitions in Institutional Real Estate Direct Investments, responsible for overseeing all aspects of the acquisition process
    CHICAGO, Aug. 4, 2022 /PRNewswire/ -- Mesirow, an independent, employee-owned financial services firm, today announced Will Beam has joined as a Managing Director, Acquisitions in Mesirow Institutional Real Estate Direct Investments.
  • Leveraging nearly 20 years of real estate investment experience and past oversight of more than $4.5 billion in real estate investments, Will's focus will be on all aspects of the acquisition process.
  • Mesirow Institutional Real Estate Direct Investments is a proven team that invests in the multi-family housing sector across the top 25-30 markets within the US.
  • Mesirow Institutional Real Estate Direct ("IRED") is a division of Mesirow Financial Investment Management, Inc., an SEC-registered investment advisor.

INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Beam Therapeutics Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Wednesday, August 3, 2022 - 4:30pm
Class Action Lawsuit, Professional Services, Legal, Ethics, Food, Suite, Company, Communication, FDA, IND, News, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Certification, NASDAQ, Security (finance), Beam

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Beam Therapeutics Inc. (Beam or the Company) (NASDAQ: BEAM ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Beam Therapeutics Inc. (Beam or the Company) (NASDAQ: BEAM ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • The Company added that the FDA indicated they will provide an official clinical hold letter to Beam within 30 days.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Beam Therapeutics Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Tuesday, August 2, 2022 - 10:32pm
Professional Services, Class Action Lawsuit, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Ethics, NASDAQ, News, Certification, FDA, Company, Suite, Communication, IND, Security (finance), Beam

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Beam Therapeutics Inc. (Beam or the Company) (NASDAQ: BEAM ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Beam Therapeutics Inc. (Beam or the Company) (NASDAQ: BEAM ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • The Company added that the FDA indicated they will provide an official clinical hold letter to Beam within 30 days.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

Beam Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference

Retrieved on: 
Tuesday, August 2, 2022 - 1:30pm
Nasdaq, DNA, Conference, Beam, Gene editing, Biotechnology, GLOBE, Patient, Fine chemical

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a panel titled, So Let it Be (Re)Written - Updates in Gene Modulation during the 2022 Wedbush PacGrow Virtual Healthcare Conference on Tuesday, August 9, 2022 at 9:45 a.m.

Key Points: 
  • CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a panel titled, So Let it Be (Re)Written - Updates in Gene Modulation during the 2022 Wedbush PacGrow Virtual Healthcare Conference on Tuesday, August 9, 2022 at 9:45 a.m.
  • Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines.
  • This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs.
  • Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM

Retrieved on: 
Monday, August 1, 2022 - 9:01pm
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, LLP, Company, GLOBE, BEAM, Food, NASDAQ, News, FDA, Communication, Pomerantz, IND, Private investigator, Beam

NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Beam Therapeutics Inc. (Beam or the Company) (NASDAQ:BEAM).

Key Points: 
  • NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Beam Therapeutics Inc. (Beam or the Company) (NASDAQ:BEAM).
  • The investigation concerns whether Beam and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Beam advised investors that [t]he FDA indicated they will provide an official clinical hold letter to Beam within 30 days.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND Application

Retrieved on: 
Monday, August 1, 2022 - 11:30am
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, DNA, GLOBE, U.S. Securities and Exchange Commission, Food, Failure, Private Securities Litigation Reform Act, Risk, Patent, Therapy, COVID-19, Biotechnology, Technology, FDA, Security (finance), Patient, Nasdaq, Annual report, Gene editing, Communication, IND, Pharmaceutical industry, Beam

The BEAM-201 IND was submitted at the end of June.

Key Points: 
  • The BEAM-201 IND was submitted at the end of June.
  • The FDA indicated they will provide an official clinical hold letter to Beam within 30 days.
  • Beam plans to provide additional updates pending discussion with the FDA.
  • Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines.

Beam Global Receives $900k Battery Order to Power Autonomous Delivery Drones

Retrieved on: 
Thursday, July 28, 2022 - 1:00pm
Acquisition, Goldman Sachs, Environment, GLOBE, Aviation, Beam Suntory, Twitter, Fortune 500, SAN, EV, Forward-looking statement, Beam, Solution, Phrase, EVS, COVID-19, Relaxation, CAGR, YouTube, Technology, LinkedIn, Nasdaq, Growth, UAV

SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Beam Global , (Nasdaq: BEEM , BEEMW), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media, announced a $927k order for Beam Globals energy storage solutions to power autonomous on-demand delivery drones.

Key Points: 
  • SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Beam Global , (Nasdaq: BEEM , BEEMW), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media, announced a $927k order for Beam Globals energy storage solutions to power autonomous on-demand delivery drones.
  • The global market for drones is expected to grow at a fantastic pace over the next decade.
  • The drones powered in this case perform delivery services for a range of applications from Fortune 100 retailers to startups and global partners.
  • The Beam Global energy storage solutions used in the autonomous drones include patented PCC technology for advanced thermal management and energy density.